Hyperstar Polyester‐Based Functional Nanotheranostics for the Targeted Drug Delivery and Treatment of Cancer
Source abstract
Abstract
Abstract In this study, we have synthesized new class of hyperstar polyester (HSPE) polymer using a functional A2B monomer and bio‐based sorbitol. We hypothesize that by incorporating sorbitol, its amphiphilic nature will give the polymer greater solubility and allow for the encapsulation of wide range of anti‐cancer therapeutics. We used potassium methoxide to catalyze the melt polymerization reaction. Using the solvent diffusion method, this polymer was used to construct polymeric nanoparticles to encapsulate therapeutics, in one step, for monitoring drug delivery and treatment. The cytotoxicity of our HSPE nanoparticles was evaluated by a cell‐based MTT assays using prostate cancer cells (LNCaP) and healthy cells (CHO). In addition, the level of internalization of our HSPE nanoparticles was evaluated using fluorescence microscopy. Results showed the HSPE nanoparticles have the capability to target and concurrently image and kill cancer cells. Taken together, these studies indicate the successful development of a new drug delivery system and demonstrated its potential use in the pharmaceutical industry and the field of medicine.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · biodegradable polymer synthesis and properties · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry Pittsburg State University 1701 S Broadway Street Pittsburg KS 66762 USA
Funding
American Chemical Society Petroleum Research Fund
References (32)
Show source-provided references
1. 10.1021/mp050042010.1021/mp0500420 ↗
2. 10.1016/S0168-3659(00)00339-410.1016/S0168-3659(00)00339-4 ↗
3. 10.1016/S0079-6700(97)00039-710.1016/S0079-6700(97)00039-7 ↗
4. 10.1016/j.progpolymsci.2007.05.01710.1016/j.progpolymsci.2007.05.017 ↗
5. 10.1002/polb.2225910.1002/polb.22259 ↗
6. 10.1016/j.progpolymsci.2011.06.00410.1016/j.progpolymsci.2011.06.004 ↗
7. Pitt C. G. · NIDA Res. Monogr. · 1981 · 28 · 232
8. 10.1007/978-94-017-1217-0_510.1007/978-94-017-1217-0_5 ↗
9. 10.3390/ma202030710.3390/ma2020307 ↗
10. Hindi S. · J. Nanosci. Nanotechnol. · 2017 · 4 · 49
11. 10.1016/S1359-6446(04)03276-310.1016/S1359-6446(04)03276-3 ↗
12. 10.1007/s11095-005-9046-210.1007/s11095-005-9046-2 ↗
13. 10.1016/j.addr.2012.03.01110.1016/j.addr.2012.03.011 ↗
14. 10.1039/c3nr34320k10.1039/c3nr34320k ↗
15. 10.1021/ja512616s10.1021/ja512616s ↗
16. 10.1021/ma00163a02910.1021/ma00163a029 ↗
17. 10.1002/(SICI)1521-3765(19980515)4:5<781::AID-CHEM781>3.0.CO;2-310.1002/(SICI)1521-3765(19980515)4:5<781::AID-CHEM781>3.0.CO;2-3 ↗
18. 10.1002/0470845821.ch110.1002/0470845821.ch1 ↗
19. 10.1021/bm025738i10.1021/bm025738i ↗
20. 10.1002/adma.20100036910.1002/adma.201000369 ↗
21. 10.1021/la903784310.1021/la9037843 ↗
22. 10.1002/pat.434710.1002/pat.4347 ↗
23. 10.1002/marc.20030029810.1002/marc.200300298 ↗
24. 10.1002/app.3902810.1002/app.39028 ↗
25. 10.1039/b404447a10.1039/b404447a ↗
26. 10.1021/mp100043h10.1021/mp100043h ↗
27. 10.1002/app.1224910.1002/app.12249 ↗
28. 10.1007/s00289-017-2260-310.1007/s00289-017-2260-3 ↗
29. 10.1038/nbt117110.1038/nbt1171 ↗
30. 10.1038/nprot.2007.39110.1038/nprot.2007.391 ↗
31. 10.1021/bm300966d10.1021/bm300966d ↗
32. Chang S. S. · Nat. Rev. Urol. · 2004 · 6 · 13